Rockefeller Capital Management
TRAW icon

Rockefeller Capital Management’s Traws Pharma TRAW Stock Holding History

Rockefeller Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16
Closed -$1K – 4095
2021
Q4 		$1K Hold
16
– – ﹤0.01% 3707
2021
Q3 		$1K Sell
16
-7
-30% -$902 ﹤0.01% 3632
2021
Q2 		$3K Hold
23
– – ﹤0.01% 3205
2021
Q1 		$8K Hold
23
– – ﹤0.01% 2707
2020
Q4 		$3K Sell
23
-8
-26% -$929 ﹤0.01% 2597
2020
Q3 		$3K Sell
31
-22
-42% -$5.44K ﹤0.01% 2373
2020
Q2 		$11K Hold
53
– – ﹤0.01% 1879
2020
Q1 		$6K Buy
+53
New +$8.32K ﹤0.01% 1918

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rockefeller Capital Management's TRAW Position: Q1 2022 in Review

Rockefeller Capital Management sold out of Traws Pharma (TRAW) in Q1 2022, closing a stake of 16 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in TRAW in Q1 2020 and held it in 8 quarters. The position peaked at $11K in Q2 2020. 30 funds tracked by Wall St. Rank hold TRAW as of Q1 2022.

  • Rockefeller Capital Management reported no remaining Traws Pharma position as of Q1 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 16 Traws Pharma shares in Q1 2022, an estimated $1K.
  • Rockefeller Capital Management first reported a position in Traws Pharma in Q1 2020 and held it in 8 quarters.
  • Rockefeller Capital Management's Traws Pharma position peaked at $11K in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2022.

Based on Rockefeller Capital Management's 13F filing for Q1 2022, filed 13 May 2022.